Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review.

Hornberger J, Chen SC, Li Q, Kakad P, Quay SC.

Curr Med Res Opin. 2015 Feb;31(2):253-62. doi: 10.1185/03007995.2014.988209. Epub 2014 Dec 3.

PMID:
25405383
[PubMed - in process]
2.

Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.

Costantino HR, Culley H, Chen L, Morris D, Houston M, Roth S, Phoenix MJ, Foerder C, Philo JS, Arakawa T, Eidenschink L, Andersen NH, Brandt G, Quay SC.

J Pharm Sci. 2009 Oct;98(10):3691-706. doi: 10.1002/jps.21690.

PMID:
19226627
[PubMed - indexed for MEDLINE]
3.

Intranasal administration of acetylcholinesterase inhibitors.

Costantino HR, Leonard AK, Brandt G, Johnson PH, Quay SC.

BMC Neurosci. 2008 Dec 10;9 Suppl 3:S6. doi: 10.1186/1471-2202-9-S3-S6. Review.

PMID:
19091003
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Inhibition of human metapneumovirus replication by small interfering RNA.

Deffrasnes C, Cavanagh MH, Goyette N, Cui K, Ge Q, Seth S, Templin MV, Quay SC, Johnson PH, Boivin G.

Antivir Ther. 2008;13(6):821-32.

PMID:
18839783
[PubMed - indexed for MEDLINE]
5.

Identification of tight junction modulating lipids.

Chen-Quay SC, Eiting KT, Li AW, Lamharzi N, Quay SC.

J Pharm Sci. 2009 Feb;98(2):606-19. doi: 10.1002/jps.21462.

PMID:
18563833
[PubMed - indexed for MEDLINE]
6.

Intranasal delivery: physicochemical and therapeutic aspects.

Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC.

Int J Pharm. 2007 Jun 7;337(1-2):1-24. Epub 2007 Mar 25. Review.

PMID:
17475423
[PubMed - indexed for MEDLINE]
7.

The Trp cage motif as a scaffold for the display of a randomized peptide library on bacteriophage T7.

Herman RE, Badders D, Fuller M, Makienko EG, Houston ME Jr, Quay SC, Johnson PH.

J Biol Chem. 2007 Mar 30;282(13):9813-24. Epub 2007 Jan 30.

PMID:
17264074
[PubMed - indexed for MEDLINE]
Free Article
8.

In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.

Leonard AK, Sileno AP, Brandt GC, Foerder CA, Quay SC, Costantino HR.

Int J Pharm. 2007 Apr 20;335(1-2):138-46. Epub 2006 Nov 16.

PMID:
17174048
[PubMed - indexed for MEDLINE]
9.

Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery.

Chen SC, Eiting K, Cui K, Leonard AK, Morris D, Li CY, Farber K, Sileno AP, Houston ME Jr, Johnson PH, Quay SC, Costantino HR.

J Pharm Sci. 2006 Jun;95(6):1364-71.

PMID:
16625659
[PubMed - indexed for MEDLINE]
10.

Advances in nasal drug delivery through tight junction technology.

Johnson PH, Quay SC.

Expert Opin Drug Deliv. 2005 Mar;2(2):281-98. Review.

PMID:
16296754
[PubMed - indexed for MEDLINE]
11.

Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits.

Sileno AP, Brandt GC, Spann BM, Quay SC.

Int J Obes (Lond). 2006 Jan;30(1):68-72.

PMID:
16172618
[PubMed - indexed for MEDLINE]
12.

Development of a novel high-concentration galantamine formulation suitable for intranasal delivery.

Leonard AK, Sileno AP, MacEvilly C, Foerder CA, Quay SC, Costantino HR.

J Pharm Sci. 2005 Aug;94(8):1736-46.

PMID:
15986464
[PubMed - indexed for MEDLINE]
13.

Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography.

Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC.

Ultrasound Med Biol. 2001 Apr;27(4):565-70.

PMID:
11368867
[PubMed - indexed for MEDLINE]
14.

Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel.

Constantinides PP, Lambert KJ, Tustian AK, Schneider B, Lalji S, Ma W, Wentzel B, Kessler D, Worah D, Quay SC.

Pharm Res. 2000 Feb;17(2):175-82.

PMID:
10751032
[PubMed - indexed for MEDLINE]
15.

Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.

Quay SC, Eisenfeld AJ.

Clin Cardiol. 1997 Oct;20(10 Suppl 1):I19-26.

PMID:
9383598
[PubMed - indexed for MEDLINE]
16.

A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.

VanWagoner M, O'Toole M, Worah D, Leese PT, Quay SC.

Invest Radiol. 1991 Nov;26(11):980-6.

PMID:
1743922
[PubMed - indexed for MEDLINE]
17.

Hepatobiliary MR imaging: first human experience with MnDPDP.

Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC.

Radiology. 1991 Jan;178(1):79-82.

PMID:
1898539
[PubMed - indexed for MEDLINE]
18.

Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.

Elizondo G, Fretz CJ, Stark DD, Rocklage SM, Quay SC, Worah D, Tsang YM, Chen MC, Ferrucci JT.

Radiology. 1991 Jan;178(1):73-8.

PMID:
1898538
[PubMed - indexed for MEDLINE]
19.

Effect of manganese (II) bis(glycinate)dichloride on Ca2+ channel function in cultured chick atrial cells.

Tan W, Barnett JV, Hehn GM, Quay SC, Galper JB.

Toxicology. 1991;68(1):63-73.

PMID:
1714640
[PubMed - indexed for MEDLINE]
20.

Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection.

Van Wagoner M, O'Toole M, Quay SC.

Invest Radiol. 1990 Sep;25 Suppl 1:S39-41. No abstract available.

PMID:
2283251
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk